All questionsPharmacology: Paxlovid (nirmatrelvir; ritonavir), all indications7 questions · 2 sourcesMechanismHow does Paxlovid work (mechanism of action)?“Nirmatrelvir is a severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) antiviral drug [see Microbiology (12.4)].” (opens the source at this quote in a new tab)CopyFlag“Nirmatrelvir is a peptidomimetic inhibitor of the SARS-CoV-2 main protease (Mpro), also referred to as 3C-like protease (3CLpro) or nonstructural protein 5 (nsp5) protease. Inhibition of SARS-CoV-2 Mpro renders it incapable of processing the viral polyproteins pp1a and pp1ab, preventing viral replication. Nirmatrelvir inhibited the activity of recombinant SARS-CoV-2 Mpro in a biochemical assay with a Ki value of 3.1 nM and an IC50 value of 19.2 nM. Nirmatrelvir was found to bind directly to the SARS-CoV-2 Mpro active site by X-ray crystallography.” (opens the source at this quote in a new tab)CopyFlag“Normal proteolysis Mpro cuts the viral polyprotein chain to produce functional proteins, which enable viral replication Inhibition of proteolysis with PAXLOVID Nirmatrelvir binds to Mpro so that functional viral proteins cannot be produced and viral replication is inhibited” (opens the source at this quote in a new tab)CopyFlagWhy does Paxlovid contain ritonavir?“Ritonavir is an HIV-1 protease inhibitor but is not active against SARS-CoV-2 Mpro. Ritonavir inhibits the CYP3A-mediated metabolism of nirmatrelvir, resulting in increased plasma concentrations of nirmatrelvir.” (opens the source at this quote in a new tab)CopyFlag“Nirmatrelvir must be co-administered with ritonavir. Failure to correctly co-administer nirmatrelvir with ritonavir may result in plasma levels of nirmatrelvir that are insufficient to achieve the desired therapeutic effect.” (opens the source at this quote in a new tab)CopyFlagIs Paxlovid active against Omicron and other variants in lab studies?“The antiviral activity of nirmatrelvir against the Omicron sub-variants BA.2, BA.2.12.1, BA.4, BA.4.6, BA.5, BF.7, BQ.1, BQ.1.11, XBB.1.5, EG.5, and JN.1 was assessed in Vero E6-TMPRSS2 cells in the presence of a P-gp inhibitor. Nirmatrelvir had a median EC50 value of 88 nM (range: 39-146 nM) against the Omicron sub-variants, reflecting EC50 value fold changes ≤1.8 relative to the USA-WA1/2020 isolate. In addition, the antiviral activity of nirmatrelvir against the SARS-CoV-2 Alpha, Beta, Gamma, Delta, Lambda, Mu, and Omicron BA.1 variants was assessed in Vero E6 P-gp knockout cells. Nirmatrelvir had a median EC50 value of 25 nM (range: 16-141 nM). The Beta variant was the least susceptible variant tested, with an EC50 value fold change of 3.7 relative to USA-WA1/2020. The other variants had EC50 value fold changes ≤1.1 relative to USA-WA1/2020.” (opens the source at this quote in a new tab)CopyFlagIs there cross-resistance between Paxlovid and remdesivir?“Cross-resistance is not expected between nirmatrelvir and remdesivir or any other anti-SARS-CoV-2 agents with different mechanisms of action (i.e., agents that are not Mpro inhibitors).” (opens the source at this quote in a new tab)CopyFlagPharmacokineticsHow is Paxlovid metabolized and eliminated?“ Nirmatrelvir (When Given With Ritonavir) Ritonavir” (opens the source at this quote in a new tab)CopyFlag“Elimination Major route of elimination Renal elimination Hepatic metabolism Half-life (T½) (hr), mean 6.05* 6.15* Oral clearance (CL/F) (L/hr), mean 8.99§ 13.92§ Metabolism Metabolic pathways Nirmatrelvir is a CYP3A substrate but when dosed with ritonavir, metabolic clearance is minimal. Major CYP3A, Minor CYP2D6 Excretion % drug-related material in feces 35.3%¶ 86.4%# % of dose excreted as total (unchanged drug) in feces 27.5%¶ 33.8%# % drug-related material in urine 49.6%¶ 11.3%# % of dose excreted as total (unchanged drug) in urine 55.0%¶ 3.5%#” (opens the source at this quote in a new tab)CopyFlag“§ 300 mg nirmatrelvir (oral suspension formulation) co-administered with 100 mg ritonavir (tablet formulation) twice daily for 3 days. ¶ Determined by 19F-NMR analysis following 300 mg nirmatrelvir oral suspension administered at 0 hr enhanced with 100 mg ritonavir at -12 hours, 0 hours, 12 hours, and 24 hours. # Determined by 14C analysis following 600 mg 14C-ritonavir oral solution (6 times the approved ritonavir dose).” (opens the source at this quote in a new tab)CopyFlagNote: Table 3 columns are nirmatrelvir (given with ritonavir) followed by ritonavir.How long does Paxlovid stay in your system (half-life)?“ Nirmatrelvir (When Given With Ritonavir) Ritonavir” (opens the source at this quote in a new tab)CopyFlag“Half-life (T½) (hr), mean 6.05* 6.15*” (opens the source at this quote in a new tab)CopyFlag“* Represents data after a single dose of 300 mg nirmatrelvir (2 × 150 mg tablet formulation) administered together with 100 mg ritonavir tablet in healthy subjects.” (opens the source at this quote in a new tab)CopyFlag“Nirmatrelvir steady state was achieved on Day 2 following administration of the approved recommended dosage and the mean accumulation ratio was approximately 2-fold.” (opens the source at this quote in a new tab)CopyFlagNote: Table 3 columns are nirmatrelvir (given with ritonavir) followed by ritonavir.ComponentsWhat are the inactive ingredients in Paxlovid?“Nirmatrelvir is available as immediate-release, film-coated tablets. Each tablet contains 150 mg nirmatrelvir with the following inactive ingredients: colloidal silicon dioxide, croscarmellose sodium, lactose monohydrate, microcrystalline cellulose, and sodium stearyl fumarate. The following are the ingredients in the film coating: hydroxy propyl methylcellulose, iron oxide red, polyethylene glycol, and titanium dioxide.” (opens the source at this quote in a new tab)CopyFlag“Ritonavir is available as film-coated tablets. Each tablet contains 100 mg ritonavir with the following inactive ingredients: anhydrous dibasic calcium phosphate, colloidal silicon dioxide, copovidone, sodium stearyl fumarate, and sorbitan monolaurate. The film coating may include the following ingredients: colloidal anhydrous silica, colloidal silicon dioxide, hydroxypropyl cellulose, hypromellose, polyethylene glycol, polysorbate 80, talc, and titanium dioxide.” (opens the source at this quote in a new tab)CopyFlag